Evidence map›Paper›PMID 40829337›Full record

ArticleMolecular pharmacology2025

Metabotropic glutamate receptor homo- and heterodimers exhibit distinct responses to orthosteric and allosteric ligands.

Tyler W McCullock, Tyler Couch, Paul J Kammermeier

Abstract read
In one paragraph

Article in Molecular pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Molecular pharmacology of mGluMolecular pharmacology · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Tyler W McCullockDepartment of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York.
Tyler CouchDepartment of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York.
Paul J KammermeierDepartment of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York. Electronic address: Paul_kammermeier@urmc.rochester.edu.

Funding

A novel system for controlling dimeric receptor composition to discover unique heterodimer pharmacologyR01MH125849 · NIMH · UNIVERSITY OF ROCHESTER · PI KAMMERMEIER, PAUL J. · 2023 to 2025
$1.2M
New Tools for Studying Receptor DimersR21NS126779 · NINDS · UNIVERSITY OF ROCHESTER · PI KAMMERMEIER, PAUL J., LUECK, JOHN D. · 2022 to 2023
$407k
Tools for studying the regulation of Homer protein splicingR03NS124987 · NINDS · UNIVERSITY OF ROCHESTER · PI KAMMERMEIER, PAUL J. · 2021 to 2021
$154k
NIMH NIH HHS R01 MH125849NINDS NIH HHS R03 NS124987NINDS NIH HHS R21 NS126779
6 · The paper itself

Abstract

Metabotropic glutamate receptors (mGlus) are obligate dimer G protein-coupled receptors that can all homodimerize and heterodimerize in select combinations. Responses of mGlu heterodimers to selective ligands, including orthosteric agonists and allosteric modulators, are largely unknown. The pharmacological properties of each group II and III mGlu homodimer (except the exclusively retinally expressed mGlu6) and several heterodimers were examined when stochastically assembled in HEK293T cells, or specifically measured using an improved G protein-mediated bioluminescence resonance energy transfer assay employing complemented fragments of Nanoluciferase. Stochastically assembled receptors adopted unique signaling characteristics. Some favored the potency, efficacy, or signaling kinetics of a dominant subunit, whereas others exhibited blended profiles reflective of a combination of homo- and heterodimers at various ratios of expressed receptor. Finally, group II and III mGlu dimers were examined for responses to selective agonists and allosteric modulators. Effects of glutamate and selective group II and III orthosteric agonists were found to result in unique concentration response profiles when examining each combination of group II and III mGlu. Effects of select allosteric modulators were examined for each mGlu2-containing dimer as well as several group III dimer pairs. Likewise, allosteric modulator effects were often unique across dimers containing the targeted subunit of the ligand being tested. The results demonstrate that mGlu dimers respond uniquely to ligands selective for just one subunit, even when they are ostensibly pharmacologically similar. SIGNIFICANCE STATEMENT: This study demonstrates novel pharmacological responses to ligands acting on metabotropic glutamate receptor heterodimers in isolation. To our knowledge, it also shows for the first time the kinetics and pharmacological properties of group II and III metabotropic glutamate receptors when expressed in pairs and assembled stochastically.

Indexed as

Receptors, Metabotropic GlutamateAllosteric RegulationHEK293 CellsHumansLigandsProtein MultimerizationLigandsReceptors, Metabotropic GlutamateDimerizationG proteinG protein–coupled receptorNeuropharmacologySignaling

Identifiers

PMID40829337
PMCPMC12597640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.